Elham Hatami
University of California, Los Angeles
H-index: 12
North America-United States
Top articles of Elham Hatami
Design and optimization of biomimetic supramolecular nanoconstruct for effective targeting and therapy for triple negative breast cancer
2023
Elham Hatami
H-Index: 7
Cross-linked nanocomplexes for drug delivery applications
2023
Elham Hatami
H-Index: 7
Development of A Novel NIR Fluorescent Probe for Breast Cancer Imaging
2023
Neeraj Chauhan
H-Index: 12
Elham Hatami
H-Index: 7
Development of Surgery Guided NIR Fluorescent Probe Nanoparticles for Cancer Imaging
2023
Neeraj Chauhan
H-Index: 12
Elham Hatami
H-Index: 7
Tannic Acid Exhibits Antiangiogenesis Activity in Nonsmall-Cell Lung Cancer Cells
ACS omega
2022/6/28
Elham Hatami
H-Index: 7
A novel in-situ nanoparticle self-assembly for combination delivery of therapeutics to non-small cell lung cancer
Cancer Research
2022/6/15
Elham Hatami
H-Index: 7
Neeraj Chauhan
H-Index: 12
An integrated single-cell multiomics approach to characterize mRNA, intracellular, and surface proteins using intracellular AbSeq and BD® AbSeq Immune Discovery Panel
The Journal of Immunology
2022/5/1
Elham Hatami
H-Index: 7
In Situ Nanoparticle Self-Assembly for Combination Delivery of Therapeutics to Non-Small Cell Lung Cancer
ACS applied bio materials
2022/2/18
Elham Hatami
H-Index: 7
Neeraj Chauhan
H-Index: 12
Gambogic acid potentiates gemcitabine induced anticancer activity in non-small cell lung cancer
European journal of pharmacology
2020/12/5
Elham Hatami
H-Index: 7
Gambogic acid: A shining natural compound to nanomedicine for cancer therapeutics
2020/8/1
Elham Hatami
H-Index: 7
Extracellular vesicles in smoking-mediated HIV pathogenesis and their potential role in biomarker discovery and therapeutic interventions
2020/4/2
Pectin-tannic acid nano-complexes promote the delivery and bioactivity of drugs in pancreatic cancer cells
Pharmaceutics
2020/3/22
Elham Hatami
H-Index: 7
Tannic acid inhibits lipid metabolism and induce ROS in prostate cancer cells
Scientific reports
2020/1/22
Elham Hatami
H-Index: 7
Design, Development and Evaluation of Dual Drug Nanomedicine for Non-Small Cell Lung Cancer
2020
Elham Hatami
H-Index: 7
